Engineered MHC class I antigens as allogenizing molecules. Potential for tumor immunotherapy.
Kesari
K V
KV
Howard Hughes Medical Institute, Rockefeller University, New York, New York 10021.
Geliebter
J
J
D000818:Animals; D018014:Gene Transfer Techniques; D006183:H-2 Antigens / Q000235:genetics / Q000276:immunology*; D007167:Immunotherapy; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*; D011994:Recombinant Proteins
D006183:H-2 Antigens; D011994:Recombinant Proteins